Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Stulln Eye Drops and Accommodative Training
NCT05107791Phase 2Withdrawn
- Sponsor
- Pacific University
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Stulln in accommodative dysfunction and asthenopia (3 arms), sponsored by Pacific University. Primary endpoints: Change in Accommodative amplitude, Change in Accommodative Facility and 2 more. Planned start Mar 2021; status: withdrawn.
02
Drugs
Stulln
03
Conditions
accommodative dysfunctionasthenopia
Beyond the preview
Go deeper on NCT05107791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05107791.